A Research Study Comparing How Well Different Doses of the Medicine NN0519-0130 Help People With Excess Body Weight Lose Weight

PHASE2CompletedINTERVENTIONAL
Enrollment

355

Participants

Timeline

Start Date

March 18, 2024

Primary Completion Date

April 10, 2025

Study Completion Date

May 1, 2025

Conditions
Obesity
Interventions
DRUG

NNC0519-0130

NNC0519-0130 will be administered subcutaneously.

DRUG

Placebo

Placebo will be administered subcutaneously.

DRUG

Tirzepatide

Tirzepatide will be administered subcutaneously.

Trial Locations (45)

2010

Momentum Clinical Research Darlinghurst, Darlinghurst

2100

Northern Beaches Clinical Research, Brookvale

2148

Paratus Clinical, Blacktown

2289

Novatrials, Kotara

3081

Austin Health, Metabolic Disorders Centre, Heidelberg Heights

3124

Emeritus Research Melbourne, Camberwell

4006

Paratus Clinical, Herston

4556

University of Sunshine Coast, Sippy Downs

5067

CMAX Clinical Research, Norwood

15243

Preferred Primary Care Physicians_Pittsburgh, Pittsburgh

21045

Centennial Medical Group, Columbia

22206

Washington Cntr Weight Mgmt, Arlington

23294

National Clin Res Inc., Richmond

23606

Health Res of Hampton Roads, Newport News

TPMG Clinical Research, Newport News

27405

Medication Mgmnt, LLC_Grnsboro, Greensboro

27408

PharmQuest Life Sciences LLC, Greensboro

27834

Physicians East Endocrinology, Greenville

28401

Accellacare, Wilmington

28625

Piedmont Healthcare, Statesville

29303

Spartanburg Medical Research, Spartanburg

29425

Medical University Of South Carolina, Charleston

32003

Northeast Research Institute, Fleming Island

32216

Jacksonville Ctr For Clin Res, Jacksonville

34429

Nature Coast Clinical Research, Crystal River

40213

L-MARC Research Center, Louisville

43215

Remington Davis Inc, Columbus

46260

Midwest Inst For Clin Res, Indianapolis

46383

Velocity Clin. Res Valparaiso, Valparaiso

60607

Cedar-Crosse Research Center, Chicago

63303

StudyMetrix Research LLC, City of Saint Peters

72143

Unity Health-Searcy Medical Center, Searcy

73072

Lynn Institute of Norman, Norman

75230

Velocity Clinical Res-Dallas, Dallas

75231

North Texas Endocrine Center, Dallas

75390

UT Southwestern Medical Center - Lingvay, Dallas

75605

DCOL Ctr for Clin Res, Longview

92627

FDRC, Costa Mesa

94598

Diablo Clinical Research, Inc., Walnut Creek

44281-9236

Family Practice Center of Wadsworth Inc., Wadsworth

19104-3317

The University of Penn Center, Philadelphia

02818

Velocity Clin Res Providence, East Greenwich

37620-7352

Holston Medical Group Pc, Bristol

565-0853

OCROM Clinic, Suita-shi

160-0008

ToCROM Clinic, Tokyo

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY